Testosterone deficiency is a late side effect of radiation therapy and chemotherapy that occurs in approximately 15% of male cancer survivors. A team led by Professor Richard Ross from the University of Sheffield investigated the relationship … “We now need interventional trials with testosterone to determine which young male cancer survivors will benefit from replacement therapy .” This article was published on Mon 22 February 2010. Image © Andrey Ushakov - Fotolia.com …
See original here:
Male cancer survivors may need extra testosterone